Literature DB >> 24571573

The GAR domain of GAS2L3 mediates binding to the chromosomal passenger complex and is required for localization of GAS2L3 to the constriction zone during abscission.

Marc Fackler1, Patrick Wolter, Stefan Gaubatz.   

Abstract

GAS2L3 is a recently identified tubulin- and actin-binding protein that regulates cytokinesis and abscission. In this study we show that GAS2L3 interacts with the chromosomal passenger complex (CPC), which plays key roles in mitosis and cytokinesis. Biochemical assays show that GAS2L3 directly interacts with the C-terminus of borealin and the N-terminus of survivin. We find that the interaction between these two CPC subunits and GAS2L3 is mediated by the conserved GAR domain of GAS2L3. We further show that the GAR domain of GAS2L3 is required for localization of GAS2L3 to the constriction zone. Taken together these data suggest that GAS2L3 is a downstream effector of the CPC during cytokinetic abscission.
© 2014 FEBS.

Entities:  

Keywords:  GAS2L3; abscission; chromosomal passenger complex; cytokinesis

Mesh:

Substances:

Year:  2014        PMID: 24571573     DOI: 10.1111/febs.12766

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  3 in total

1.  GAS2L3: Coordinator of cardiomyocyte cytokinesis?

Authors:  Marco Gründl; Felix B Engel; Stefan Gaubatz
Journal:  Cell Cycle       Date:  2017-09-22       Impact factor: 4.534

2.  Deletion of Gas2l3 in mice leads to specific defects in cardiomyocyte cytokinesis during development.

Authors:  Sabine Stopp; Marco Gründl; Marc Fackler; Jonas Malkmus; Marina Leone; Ronald Naumann; Stefan Frantz; Elmar Wolf; Björn von Eyss; Felix B Engel; Stefan Gaubatz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-11       Impact factor: 11.205

3.  Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis.

Authors:  Chunyan Zhao; Nan Zhang; Xiaoteng Cui; Xinxin Zhang; Yuanyuan Ren; Chao Su; Jinyan He; Wei Zhang; Xiaoming Sun; Jie Yang; Xingjie Gao
Journal:  Cancer Med       Date:  2021-03-12       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.